Professor, Medicine, Baylor College of Medicine

Internal Medicine

Daniel Musher is an expert in the field of Internal Medicine. He went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care He over the years received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Daniel Musher is a published doctor. He published 87 publications, including: 'Postobstructive Pneumonia: An Underdescribed Syndrome.'

Publications

---

• Postobstructive Pneumonia: An Underdescribed Syndrome.
• Response: predicting poor outcomes in community-acquired pneumonia.
• Aerococcal Infection at Three US Tertiary Care Hospitals.
• The yield of sputum culture in bacteremic pneumococcal pneumonia after initiation of antibiotics.
• Clinical Prediction Rules in Community-Acquired Pneumonia: Lies, Damn Lies, and Statistics.
• The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries.
• Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia.
• Spinal and paraspinal pneumococcal infections-a review.
• Serum Procalcitonin Level, Viral Polymerase Chain Reaction Analysis, and Lower Respiratory Tract Infection.
• Reply to Bruns et al.
• Photo quiz: to scan or not to scan?
• Erratum to: Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.
• Long-term survival following pneumococcal pneumonia.
• Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study.
• How Effective is Vaccination in Preventing Pneumococcal Disease?
• Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.
• The impact of statin and macrolide use on early survival in patients with pneumococcal pneumonia.
• IRIS iQ200 workstation as a screen for performing urine culture.
• It's Not That Simple.
• Reply to Truck et al.
• Pneumococcal pyomyositis: report of 2 cases and review of the literature.
• Acute kidney injury associated with trimethoprim/sulfamethoxazole.
• Should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?
• Cardiac Complications in Patients with Community Acquired Pneumonia: Incidence, Timing, Risk Factors, and Association with Short-Term Mortality.
• The incidence of necrotizing changes in adults with pneumococcal pneumonia.
• Severe Pulmonary Involvement in a Case Attributed to Domestically Acquired Seoul Hantavirus in the United States.
• Antibody persistence 10 years after 1st and 2nd doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of 2nd and 3rd doses in older adu...
• Immunomodulatory agents in the treatment of community-acquired pneumonia: A systematic review.
• Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia.
• New modalities in treating pneumococcal pneumonia.
• V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons.
• The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?
• Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture re...
• The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century.
• Preventing myocardial infarction with vaccination: myths and realities.
• Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle...
• Role of acute infection in triggering acute coronary syndromes.
• The naming of strep, with apologies to T. S. Eliot.
• Dichotomy between content and interpretation.
• Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes.
• Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital.
• A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection.
• Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis.
• Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
• Clinical and microbiological end points in the treatment of pneumonia.
• Neurosyphilis: diagnosis and response to treatment.
• Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal ...
• Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a pros...
• Treatment of clostridium difficile colitis in the critical care setting.
• Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis.
• The long-term outcome of treatment of Clostridium difficile colitis.
• Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay.
• The association between pneumococcal pneumonia and acute cardiac events.
• Clostridium difficile: recent epidemiologic findings and advances in therapy.
• A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus.
• Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.
• Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection.
• Nitazoxanide for the treatment of Clostridium difficile colitis.
• Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis.
• An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease.
• Pneumococcal vaccine--direct and indirect ("herd") effects.
• Epidemic Clostridium difficile.
• Undisclosed conflicts of interest.
• Pneumococcal serotypes and virulence.
• Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
• Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
• Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal p...
• The usefulness of sputum gram stain and culture.
• Secondary syphilitic lesions.
• Contagious acute gastrointestinal infections.
• Anemia and infection.
• In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
• Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia.
• Clostridium difficile infection in patients with unexplained leukocytosis.
• Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
• A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
• Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vac...
• Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis.
• How contagious are common respiratory tract infections?
• Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
• Diagnosis still in question.
• The lack of therapeutic benefit of adding hydroxyurea to highly active antiretroviral therapy (HAART).
• Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile.
• Emergence of macrolide resistance during treatment of pneumococcal pneumonia.
• Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria.
• Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia.

Schools

---

• Columbia University College of Physicians And Surgeons

• Bellevue Hospital Columbia Division

• Tufts New Engl Med Center

Doctors Specialties

---

• Infectious Disease Medicine
• Internal Medicine

Accepted Insurances

---

Awards

---

• Elected Member
• Whos Who in Medicine and Healthcare

Education

---

• Tufts Medical Center
• NYU School of Medicine
• Columbia University College of Physicians & Surgeons

Hospital

---

• Michael E. DeBakey Veterans Affairs Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Afroze Ali, MD This Doctor is OpenDoctor Recommended.
	Dr. Donald M. Marcus, MD This Doctor is OpenDoctor Recommended.
	Dr. Stanley T. Lewis Jr., MD
	Dr. John R. Strawn, MD This Doctor is OpenDoctor Recommended.
	Dr. Leonard G. Kibert, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew L. Goers, MD
	Dr. Samuel Chen, MD
	Dr. Ahmed A. Salahudeen, MD
	Dr. Stephen R. Huff, MD This Doctor is OpenDoctor Recommended.
	Dr. Muhammad Y. Shaikh, MD This Doctor is OpenDoctor Recommended.
	Dr. Walid A. Baaklini, MD This Doctor is OpenDoctor Recommended.
	Dr. Layne O. Gentry, MD This Doctor is OpenDoctor Recommended.
	Dr. Marlos R. Fernandes, MD This Doctor is OpenDoctor Recommended.
	Dr. Monisha Arya, MD This Doctor is OpenDoctor Recommended.
	Dr. Coralia N. Mihu, MD This Doctor is OpenDoctor Recommended.
	Dr. Barbara E. Murray, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. George Kannankeril, MD This Doctor is OpenDoctor Recommended.
	Dr. Majd K. Jwied, MD This Doctor is OpenDoctor Recommended.
	Dr. Angel A. Rodriguez, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog